Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
European Journal of Clinical Pharmacology|October 7, 2022
The safety of systemic Janus kinase inhibitors in atopic dermatitis: a systematic review and network meta-analysisCarlos Alves, Ana Penedones, Diogo Mendes, et al.Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|July 30, 2014
Safety monitoring of ophthalmic biologics: a systematic review of pre- and postmarketing safety dataAna Penedones, Diogo Mendes, Carlos Alves, et al.International Journal of Clinical Pharmacy|April 19, 2023
Topical Janus kinase inhibitors in atopic dermatitis: a safety network meta-analysisCarlos Alves, Ana Penedones, Diogo Mendes, et al.Clinicoeconomics and Outcomes Research : CEOR|September 8, 2016
A systematic review of observational studies evaluating costs of adverse drug reactionsFrancisco Batel Marques, Ana Penedones, Diogo Mendes, et al.Acta Ophthalmologica|February 6, 2016
A systematic review and meta-analysis of the association between systemic fluoroquinolones and retinal detachmentCarlos Alves, Ana Penedones, Diogo Mendes, et al.Journal of Patient Safety|December 21, 2016
Outcomes From the First 6 Years of Operation of the Central Portugal Pharmacovigilance UnitFrancisco Batel-Marques, Ana Penedones, Diogo Mendes, et al.Cureus|September 26, 2025
Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and the Risk of Acute Pancreatitis: A Systematic Review and Meta-AnalysisCarlos Alves, Beatriz Costa, Ana Penedones, et al.BMJ Open|September 19, 2019
Effectiveness in clinical practice versus efficacy of dipeptidyl peptidase-4 inhibitors in clinical trials for type 2 diabetes: protocol for systematic reviewFrancisco Batel-Marques, Diogo Pereira, Diogo Mendes, et al.Ophthalmic Research|July 13, 2016
Risk of Ophthalmic Adverse Effects in Patients Treated with MEK Inhibitors: A Systematic Review and Meta-AnalysisCarlos Alves, Inês Ribeiro, Ana Penedones, et al.Current Drug Safety|July 30, 2015
The Role of Disproportionality Analysis of Pharmacovigilance Databases in Safety Regulatory Actions: a Systematic ReviewPatrícia Dias, Ana Penedones, Carlos Alves, et al.Pageof 3